[
    [
        {
            "time": "2020-12-01",
            "original_text": "富力地产11月份权益合约销售升7%至146亿元；中国软件国际与深圳市政府达成战略合作协议",
            "features": {
                "keywords": [
                    "富力地产",
                    "权益合约销售",
                    "中国软件国际",
                    "深圳市政府",
                    "战略合作协议"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "房地产",
                    "软件行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "富力地产11月份权益合约销售升7%至146亿元；中国软件国际与深圳市政府达成战略合作协议",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-01",
            "original_text": "慧聪集团附属兆信信息引入复星集团等为战略股东，产业互联网之路再添新动力",
            "features": {
                "keywords": [
                    "慧聪集团",
                    "兆信信息",
                    "复星集团",
                    "战略股东",
                    "产业互联网"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "信息技术",
                    "互联网"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "慧聪集团附属兆信信息引入复星集团等为战略股东，产业互联网之路再添新动力",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-01",
            "original_text": "复星医药控股股东复星高科技增持137万股公司H股股份",
            "features": {
                "keywords": [
                    "复星医药",
                    "复星高科技",
                    "增持",
                    "H股"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药控股股东复星高科技增持137万股公司H股股份",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-12-01",
            "original_text": "疫情叠加集采致业绩大降，中国生物制药暴跌11%，盈利能力下降",
            "features": {
                "keywords": [
                    "疫情",
                    "集采",
                    "中国生物制药",
                    "盈利能力"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫情叠加集采致业绩大降，中国生物制药暴跌11%，盈利能力下降",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "2020-12-01",
            "original_text": "药监局加强带量采购中标冠脉支架质量监管，国药集团提交新冠疫苗上市申请",
            "features": {
                "keywords": [
                    "药监局",
                    "带量采购",
                    "冠脉支架",
                    "国药集团",
                    "新冠疫苗",
                    "上市申请"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药监局加强带量采购中标冠脉支架质量监管，国药集团提交新冠疫苗上市申请",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]